These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8758361)

  • 21. Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication.
    van Bömmel F; Wünsche T; Schürmann D; Berg T
    Hepatology; 2002 Aug; 36(2):507-8. PubMed ID: 12143063
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanism of emergence of hepatitis B virus escape variants: approaches to prevention.
    Thomas HC
    J Viral Hepat; 1998 Nov; 5 Suppl 2():31-6. PubMed ID: 9857358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological features of hepatitis B virus isolates from patients based on full-length genomic analysis.
    Wen YM; Wang YX
    Rev Med Virol; 2009 Jan; 19(1):57-64. PubMed ID: 19058172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel hepatitis B virus variant S 129 (Gln-->Leu): lack of correlation between antigenicity and immunogenicity.
    Wu L; He JW; Yao X; Li HM; Wen YM
    J Med Virol; 1999 Dec; 59(4):424-30. PubMed ID: 10534722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Selective transmission of hepatitis B virus variant with S gene mutation between HBV-carrier mothers and their infants].
    Zhang J; Wang ZH; Hou JL; Yang H; Cheng AL; Li XH
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Sep; 22(9):806-7, 810. PubMed ID: 12297437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation.
    Liu CJ; Chen PJ; Lai MY; Kao JH; Chang CF; Wu HL; Shau WY; Chen DS
    Gastroenterology; 2003 Jan; 124(1):80-90. PubMed ID: 12512032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccines for neonatal viral infections: hepatitis B vaccine.
    Cutts FT; Hall AJ
    Expert Rev Vaccines; 2004 Aug; 3(4):349-52. PubMed ID: 15270632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus genotypes: a South Pacific perspective.
    Harrison GL; Murray-McIntosh R; Penny D
    Pac Health Dialog; 2001 Mar; 8(1):188-92. PubMed ID: 12017822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Establishment and identification of highly expressing and replicating hepatitis B virus genome transgenic mouse models].
    Wu Jm; Lin JS; Chen BT; Zheng XM; Zhao HB; Liang KH
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):338-40. PubMed ID: 12837210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure and selection of hepatitis B virus variants during the natural course of infection and interferon therapy.
    Günther S; Miska S; Meisel H; Will H
    Princess Takamatsu Symp; 1995; 25():211-20. PubMed ID: 8875626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab.
    Miyagawa M; Minami M; Fujii K; Sendo R; Mori K; Shimizu D; Nakajima T; Yasui K; Itoh Y; Taniwaki M; Okanoue T; Yoshikawa T
    J Med Virol; 2008 Dec; 80(12):2069-78. PubMed ID: 19040281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-spliced defective hepatitis B virus genome derived from hepatocellular carcinoma tissue enhanced replication of full-length virus.
    Ma ZM; Lin X; Wang YX; Tian XC; Xie YH; Wen YM
    J Med Virol; 2009 Feb; 81(2):230-7. PubMed ID: 19107969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses.
    De Mitri MS; Morsica G; Cassini R; Bagaglio S; Andreone P; Bianchi G; Loggi E; Bernardi M
    Arch Virol; 2007 Feb; 152(2):395-404. PubMed ID: 16953307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatitis B vaccine in patients with human immunodeficiency virus infection].
    Ramírez O CA; Fernández A DG; Valderrama B SL; Gómez Q CH; Támara R JR; Alvarez M CA
    Rev Chilena Infectol; 2009 Feb; 26(1):26-33. PubMed ID: 19350156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatitis B virus mutants--clinical significance].
    Blum HE; Moradpour D; vøn Weizsäcker F; Wieland S; Peters T; Rasenack JW
    Z Gastroenterol; 1997 May; 35(5):347-55. PubMed ID: 9265394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biology of hepatitis B virus variants.
    Feitelson MA
    Lab Invest; 1994 Sep; 71(3):324-49. PubMed ID: 7933984
    [No Abstract]   [Full Text] [Related]  

  • 37. The global impact of vaccination against hepatitis B: a historical overview.
    Zanetti AR; Van Damme P; Shouval D
    Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro characterization of viral fitness of therapy-resistant hepatitis B variants.
    Villet S; Billioud G; Pichoud C; Lucifora J; Hantz O; Sureau C; Dény P; Zoulim F
    Gastroenterology; 2009 Jan; 136(1):168-176.e2. PubMed ID: 18996386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus S gene mutants in infants infected despite immunoprophylaxis.
    Zhu Q; Lu Q; Xiong S; Yu H; Duan S
    Chin Med J (Engl); 2001 Apr; 114(4):352-4. PubMed ID: 11780452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Screening for hepatitis B].
    Krogsgaard K
    Ugeskr Laeger; 2002 Jan; 164(2):159-62. PubMed ID: 11831078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.